Home Nucleus Pharmaceuticals Israel Influenza Drug Market to 2032

Israel Influenza Drug Market to 2032

Overview

The Israel Influenza Drug Market is expected to reach a 115.74 USD Million by 2032 and is projected to grow at a CAGR of 5.43% from 2025 to 2032.

Revenue, 2024 (USD Million)
82.07
Forecast, 2032 (USD Million)
115.74
CAGR, 2024 - 2032
5.43%
Report Coverage
Israel

Israel Influenza Drug Market 2018-2032 USD Million

Israel Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 82.07 USD Million
  • Projected Market Size (2032): 115.74 USD Million
  • CAGR (2025-2032): 5.43%

Key Findings of Israel Influenza Drug Market

  • The Israel Influenza Drug Market was valued at 82.07 USD Million in 2024.
  • The Israel Influenza Drug Market is likely to grow at a CAGR of 5.43% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 141.98 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 6.31% during the forecast period from 2024 to 2032.

Israel Influenza Drug Market Scope

Israel Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Treatment
  • Drugs
  • Vaccines
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Homecare
  • Hospitals
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults

Israel Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 82.07 USD Million
Market Value in 2032 115.74 USD Million
CAGR (2025-2032) 5.43%
Historic Data 2016-2023
Market Segments Covered Type,Treatment,Distribution Channel,End User,Route of Administration,Age

Regional Insights:

  • Leading Market (2024-2032): Israel, leading in terms of revenue 82.07 USD Million in 2024
    • Key Country: Israel, leading in terms of revenue with value of 82.07 USD Million in 2024.

Segments and Scope

  • Israel Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 36.98 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 5.99 % in forecast period 2025-2032.
  • Israel Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 141.98 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 5.46 % in forecast period 2025-2032.
  • Israel Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 44.29 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 5.79 % in forecast period 2025-2032.
  • Israel Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 58.54 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 5.61 % in forecast period 2025-2032.
  • Israel Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 33.71 USD Million in the year 2024.
    • Oral is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 6.31 % in forecast period 2025-2032.
  • Israel Influenza Drug Market to 2032, By Age
    • Adults is the largest segment in Israel Influenza Drug Market to 2032 with a revenue of 42.50 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in Israel Influenza Drug Market to 2032 with a Growth rate of 4.96 % in forecast period 2025-2032.

Israel Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
Israel Influenza Drug Market Company Share Analysis

Israel Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Israel Influenza Drug Market Company Profiling

Israel Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Israel Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
Israel Influenza Drug Market was valued at USD 82.07(Revenue in USD Million) in 2022.
Israel Influenza Drug Market is projected to grow at a CAGR of 5.43% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Israel Influenza Drug Market, holding a largest market share of 141.98 USD Million in 2024

Israel Influenza Drug Market Scope

Israel Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Treatment
  • Drugs
  • Vaccines
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Homecare
  • Hospitals
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
Frequently Asked Questions
The Israel Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
Israel Influenza Drug Market was valued at USD 82.07(Revenue in USD Million) in 2022.
Israel Influenza Drug Market is projected to grow at a CAGR of 5.43% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Influenza Drug Market for final year is USD 115.74 (USD Million).

Israel Influenza Drug Market Company Profiling

Israel Influenza Drug Market Company Profiling
Frequently Asked Questions
The Israel Influenza Drug Market is segmented based on Segmentation Type,Treatment,Distribution Channel,End User,Route of Administration,Age.
Israel Influenza Drug Market was valued at USD 82.07(Revenue in USD Million) in 2022.
Israel Influenza Drug Market is projected to grow at a CAGR of 5.43% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Influenza Drug Market for final year is USD 115.74 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES